Better understanding of the roles of IGF-binding proteins as potential modulators of the association between IGF1 and breast-cancer risk might come from further data on IGFBP1 and IGFBP2, from measures of intact IGFBP3,54 or from measures of bioavailable IGF1.55 Here, IGFBP3 is linked to breast carcinoma.